Heart Failure in COVID-19: The Multicentre, Multinational PCHF-COVICAV Registry
Mateusz Sokolski(Wroclaw Medical University), Frank Ruschitzka(Kantonsspital St. Gallen), Michał Marchel, Stephan Winnik(Heart and Diabetes Center North Rhine-Westphalia), Anne–Catherine Pouleur(Cliniques Universitaires Saint-Luc), Pascal S. Heiniger(University of Zurich), Piotr Ponikowski(Wroclaw Medical University), Goran Loncar(Institute for Cardiovascular Diseases of Vojvodina), Claire Bouleti(Inserm), Klemens Ablasser(Medical University of Graz), Margherita Gaudenzi(University of Milan), Viktoria Muster(Medical University of Graz), Nathan Mewton(Hospices Civils de Lyon), Nana K. Poku, Kristoffer Grundtvig Skaarup(University of Copenhagen), Gianfranco Sinagra(Società Italiana di Cardiologia), Edgard A. Prihadi(ZNA Middelheim Hospital), Irina Cabac‐Pogorevici(Nicolae Testemițanu State University of Medicine and Pharmacy), Eduardo Barge‐Caballero(Instituto de Salud Carlos III), Ahmet Çelik(Ege University), Philippe Meyer(National and Kapodistrian University of Athens), Aris Bechlioulis(University of Ioannina), Domenico D’Amario(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Peter P. Rainer(Tirol Kliniken), Alessandra Chiodini(University of Zurich), Yuya Matsue(Juntendo University), Mats Christian Højbjerg Lassen(University of Copenhagen), Marcus Dörr(University of Freiburg), Massimo Mapelli(University of Milan), Marzia Lilliu(Azienda Ospedaliera Universitaria Integrata Verona), Carlos Eduardo Lucena Montenegro(Universidade Federal de Pernambuco), Fran Mikulicic(University Hospital of Zurich), Jeroen Dauw(Onze Lieve Vrouwziekenhuis Hospital), Justyna M. Sokolska(Wroclaw Medical University), Felix Schoenrath(Deutsches Herzzentrum der Charité), Davide Stolfo(Azienda Sanitaria Universitaria Integrata di Trieste), Markus Wallner(Medical University of Graz), Lars H. Lund(Karolinska University Hospital), Giuseppe Rosano(St George's Hospital), Daniel Messroghli(German Centre for Cardiovascular Research), Tor Biering‐Sørensen(Copenhagen University Hospital), Hüseyin Altuğ Çakmak(Istanbul University-Cerrahpaşa), Wilfried Müllens(Ziekenhuis Oost-Limburg), Irene Mattavelli(Centro Cardiologico Monzino), Jérôme Costa(Centre Hospitalier Universitaire de Reims), Lampros K. Michalis(University Hospital of Ioannina), Matthias Paul, Chiara Minoia(Ospedale di Circolo di Busto Arsizio), Judith Schwaiger(University of Zurich), Sander Trenson(KU Leuven)
Cited by 45
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k